Cargando…
COVID-19 and conjunctivitis: a meta-analysis
COVID-19 is a disease first identified in Wuhan City, Hubei Province, China, in December 2019, causes by a SARS-COV-2 virus infection. By 27 October 2020, 43,921,473 confirmed cases were reported worldwide, with 1,166,389 COVID-19 deaths. Conjunctivitis has been reported in adults and pediatric pati...
Autor principal: | Al-Namaeh, Mashael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994922/ https://www.ncbi.nlm.nih.gov/pubmed/34192224 http://dx.doi.org/10.1177/25158414211003368 |
Ejemplares similares
-
The prevalence of mental health outcomes among eating disorder patients during the COVID-19 pandemic: A meta-analysis
por: Khraisat, Bann Rami, et al.
Publicado: (2022) -
Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression
por: Atmosudigdo, Indriwanto Sakidjan, et al.
Publicado: (2021) -
Coronavirus disease 2019 (Covid-19) outcomes in patients with sarcopenia: A meta-analysis and meta-regression
por: Siahaan, Yusak Mangara Tua, et al.
Publicado: (2022) -
Multisystem inflammatory syndrome in pediatric COVID-19 patients: a meta-analysis
por: Toraih, Eman A., et al.
Publicado: (2021) -
Lipid profile as an indicator of COVID-19 severity: A systematic review and meta-analysis
por: Mahat, Roshan Kumar, et al.
Publicado: (2021)